Indeed, EVs derived from both GBM and melanoma cells have been shown to locally and systemically suppress the activation of CD8+ T cells in a PD-L1–dependent manner (40, 41) and to alter the fate of tumor-associated macrophages (42). This evidence concerns the gene CD274 and neoplasm.